We are live on ! Find out more
DALS

DA32 Life Science Tech Acquisition Corp

Delisted

DALS was delisted on the 28th of July, 2023.

50 hedge funds and large institutions have $171M invested in DA32 Life Science Tech Acquisition Corp in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 7

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

6% more funds holding

Funds holding: 47 → 50 (+3)

1.64% more ownership

Funds ownership: 80.4% → 82.04% (+1.6%)

8% more capital inflows, than outflows

Capital inflows: $51.4M | Capital outflows: $47.7M

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
50
Holders Change
+3
Holders Change %
+6.38%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
13
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

DALS Hedge Fund Activity: Q1 2023 in Review

50 of the 6,291 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp (DALS) for Q1 2023, worth a combined $171M — up 3.5% from $166M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new DALS positions and 6 closed out — a net gain of 3 holders — while 13 added to existing stakes and 7 trimmed.

The largest buyer was First Trust Capital Management, opening a new position worth an estimated $23.7M. The largest seller was RA Capital Management, exiting entirely with an estimated $15M sold.

  • 50 institutional investors held DA32 Life Science Tech Acquisition Corp (DALS) as of Q1 2023, up from 47 in Q4 2022.
  • Funds reported $171M of DA32 Life Science Tech Acquisition Corp stock for Q1 2023, up 3.5% quarter-over-quarter.
  • 9 funds opened new DA32 Life Science Tech Acquisition Corp positions in Q1 2023 and 6 closed out, a net change of +3 holders.
  • The largest DA32 Life Science Tech Acquisition Corp buyer in Q1 2023 was First Trust Capital Management, an estimated $23.7M added.
  • The largest DA32 Life Science Tech Acquisition Corp seller in Q1 2023 was RA Capital Management, an estimated $15M sold.

Based on aggregated 13F filings for Q1 2023.